BRIEF-Sangamo says patient received therapy intended to precisely edit DNA of cells directly inside body​

* Sangamo announces treatment of first patient in landmark phase 1/2 clinical trial evaluating in vivo genome editing for MPS II

Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

Whoops, looks like something went wrong.